Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years

Enrolling by invitation · Not applicable

Conditions studied: Fuchs Endothelial Corneal Dystrophy, Corneal Endothelial Decompensation

In brief

This multi-center clinical trial is designed to assess the association of diabetes in a cornea donor with transplant success and loss of endothelial cells 5 years following Descemet membrane endothelial keratoplasty (DMEK). Study eyes are assigned to receive either a cornea from a donor without diabetes or a cornea from a donor with diabetes in a masked fashion.

Key facts

Study ID
NCT07217249
Run by
Case Western Reserve University
People needed
570
Starts
2025-12-03
Expected to finish
2030-04-30
Last updated by the study team
2026-02-27

Who can join

Age: 30 and older, up to 93. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.